Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Healthequity (HQY) Interest Expenses (2016 - 2026)

Healthequity has reported Interest Expenses over the past 13 years, most recently at $13.3 million for Q1 2026.

  • Quarterly results put Interest Expenses at $13.3 million for Q1 2026, down 13.03% from a year ago — trailing twelve months through Jan 2026 was $57.1 million (down 5.78% YoY), and the annual figure for FY2026 was $57.1 million, down 5.78%.
  • Interest Expenses for Q1 2026 was $13.3 million at Healthequity, down from $14.0 million in the prior quarter.
  • Over the last five years, Interest Expenses for HQY hit a ceiling of $18.2 million in Q4 2024 and a floor of $10.5 million in Q2 2022.
  • Median Interest Expenses over the past 5 years was $13.6 million (2024), compared with a mean of $13.7 million.
  • Biggest five-year swings in Interest Expenses: skyrocketed 58.74% in 2022 and later dropped 22.62% in 2025.
  • Healthequity's Interest Expenses stood at $12.2 million in 2022, then increased by 11.34% to $13.5 million in 2023, then soared by 34.03% to $18.2 million in 2024, then decreased by 22.62% to $14.0 million in 2025, then dropped by 5.55% to $13.3 million in 2026.
  • The last three reported values for Interest Expenses were $13.3 million (Q1 2026), $14.0 million (Q4 2025), and $15.0 million (Q3 2025) per Business Quant data.